This inventor holds 1 USPTO granted patent. Top assignee: Peking Union Medical College. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Kang Zhou - Innovator in Autoimmune Myocarditis Research
Introduction
Kang Zhou is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical research, particularly in the area of autoimmune myocarditis. His innovative work has led to the development of a unique animal model that closely simulates the clinical conditions faced by patients undergoing treatment with anti-PD-1/PD-L1 monoclonal antibodies.
Latest Patents
Kang Zhou holds a patent for a mouse model of myocarditis. This patent describes a preparation method for an anti-PD-1/PD-L1 monoclonal antibody-induced autoimmune myocarditis model. The method involves mediating a model with adeno-associated virus 9 (AAV9) to achieve high expression of PDL1 in myocardial tissue. Subsequently, an anti-PD-1/PD-L1 monoclonal antibody is applied to the model with high PDL1 expression in the myocardial tissue for effective modeling. The model developed through this method accurately simulates the pathogenesis and clinical course of autoimmune myocarditis in patients treated with anti-PD-1/PD-L1 monoclonal antibodies. It closely resembles the pathophysiological status of clinical patients, boasts a high modeling rate, and allows for dynamic monitoring.
Career Highlights
Kang Zhou is affiliated with Peking Union Medical College Hospital, where he conducts his research. His work has garnered attention for its potential to improve understanding and treatment of autoimmune myocarditis. His innovative approach to modeling this condition has opened new avenues for research and therapeutic strategies.
Collaborations
Kang Zhou collaborates with esteemed colleagues, including Yining Wang and Chanjuan Qu. Their combined expertise enhances the research efforts and contributes to the advancement of knowledge in the field of autoimmune diseases.
Conclusion
Kang Zhou's contributions to the field of autoimmune myocarditis research are noteworthy. His innovative patent and collaborative efforts position him as a key figure in advancing medical research and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile